Sign In
Buy OPY
$99.90
+2.52 (+2.59%)
At Close: Jun 09, 2026
Personalis to Post Q2 2020 Earnings of ($0.32) Per Share, Oppenheimer Forecasts (NASDAQ:PSNL)
01:16am, Tuesday, 30'th Jun 2020
Personalis (NASDAQ:PSNL) – Stock analysts at Oppenheimer raised their Q2 2020 earnings per share (EPS) estimates for Personalis in a research note issued on Wednesday, June 24th. Oppenheimer analyst
GSE forbearance rate drops for third week, MBA says - HousingWire
01:16am, Tuesday, 30'th Jun 2020
Overall, the forbearance rate of mortgages backed by Fannie Mae and Freddie Mac fell one basis point to 8.48%, representing 4.2 million mortgages, MBA said.
Carlyle Buys 20% Stake in Piramal’s Pharma Business For $490 Million
07:18pm, Monday, 29'th Jun 2020
The Carlyle Group (CG) announced that it has agreed to purchase a 20% stake in the pharmaceutical business of Indian Piramal Enterprises Ltd. for about
Fixed-Rate Mortgage: What It Is And When To Use One
03:14pm, Monday, 29'th Jun 2020
A fixed-rate mortgage is a type of loan that is secured by real estate and has an interest rate that remains unchanged during the mortgage term. These mortgages are ideal for borrowers who want to lo
Intercept Pharmaceuticals (NASDAQ:ICPT) Lowered to Hold at Canaccord Genuity
01:36pm, Monday, 29'th Jun 2020
Intercept Pharmaceuticals (NASDAQ:ICPT) was downgraded by stock analysts at Canaccord Genuity from a “buy” rating to a “hold” rating in a research note issued to investors on Monday, Briefing.
Analyst Explains Why They Downgraded Their Rating on Intercept Pharma (ICPT) - Markets
01:29pm, Monday, 29'th Jun 2020
In a report released today, Jay Olson from Oppenheimer downgraded Intercept Pharma (ICPT – Research Report) to Hold, with a
Analysts Anticipate 8×8, Inc. (NYSE:EGHT) Will Post Earnings of -$0.13 Per Share
01:28pm, Monday, 29'th Jun 2020
Analysts expect 8×8, Inc. (NYSE:EGHT) to announce ($0.13) earnings per share for the current fiscal quarter, Zacks Investment Research reports. Four analysts have issued estimates for 8X8’s earning
-$0.25 EPS Expected for Tactile Systems Technology Inc (NASDAQ:TCMD) This Quarter
12:34pm, Monday, 29'th Jun 2020
Equities analysts expect Tactile Systems Technology Inc (NASDAQ:TCMD) to announce ($0.25) earnings per share for the current quarter, according to Zacks. Three analysts have made estimates for Tactile
Weekly Research Analysts’ Ratings Changes for Paypal (PYPL)
12:22pm, Monday, 29'th Jun 2020
Several brokerages have updated their recommendations and price targets on shares of Paypal (NASDAQ: PYPL) in the last few weeks: 6/26/2020 – Paypal had its price target raised by analysts at Bank o
Recent Investment Analysts’ Ratings Updates for Corbus Pharmaceuticals (CRBP)
12:22pm, Monday, 29'th Jun 2020
Corbus Pharmaceuticals (NASDAQ: CRBP) recently received a number of ratings updates from brokerages and research firms: 6/26/2020 – Corbus Pharmaceuticals was upgraded by analysts at BidaskClub from
IQIYI (IQ) – Research Analysts’ Weekly Ratings Changes
12:22pm, Monday, 29'th Jun 2020
A number of firms have modified their ratings and price targets on shares of IQIYI (NASDAQ: IQ) recently: 6/25/2020 – IQIYI was downgraded by analysts at Oppenheimer Holdings Inc. from an “outperf
$57.04 Million in Sales Expected for Limelight Networks, Inc. (NASDAQ:LLNW) This Quarter
12:20pm, Monday, 29'th Jun 2020
Equities research analysts predict that Limelight Networks, Inc. (NASDAQ:LLNW) will post sales of $57.04 million for the current quarter, Zacks Investment Research reports. Five analysts have made est
Leerink Partners Remains a Hold on Intersect ENT (XENT) - Markets
11:56am, Monday, 29'th Jun 2020
In a report released today, Richard Newitter from Leerink Partners maintained a Hold rating on Intersect ENT (XENT – Research
$22.70 Million in Sales Expected for Crispr Therapeutics AG (NASDAQ:CRSP) This Quarter
11:38am, Monday, 29'th Jun 2020
Wall Street analysts forecast that Crispr Therapeutics AG (NASDAQ:CRSP) will report $22.70 million in sales for the current fiscal quarter, Zacks reports. Five analysts have provided estimates for Cri
Global Payments (NYSE:GPN) PT Raised to $202.00
11:18am, Monday, 29'th Jun 2020
Global Payments (NYSE:GPN) had its price objective hoisted by equities researchers at Oppenheimer from $190.00 to $202.00 in a research note issued on Monday, The Fly reports. The brokerage currently
